Fortress Biotech, Inc. (FBIO)
3.32
+0.39
(+13.31%)
USD |
NASDAQ |
Dec 15, 16:00
3.37
+0.05
(+1.51%)
After-Hours: 06:45
Fortress Biotech Research and Development Expense (Annual): 56.88M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Journey Medical Corp. | 9.857M |
| Ultragenyx Pharmaceutical, Inc. | 667.82M |
| Axsome Therapeutics, Inc. | 186.54M |
| Apellis Pharmaceuticals, Inc. | 327.57M |
| Absci Corp. | 63.86M |